Bpifrance

Bpifrance Financement S.A. is a French financial institution that provides a wide range of financing solutions and support services for businesses at various stages of their development. Established in 1980 and based in Maisons-Alfort, France, the company offers medium to long-term loans, export insurance, real estate and equipment leasing, and working capital loans. Bpifrance also invests in startups, small and medium-sized enterprises (SMEs), and mid-cap companies through direct investments and fund management activities. Additionally, it provides consulting services for executives and training for CEOs, aiming to facilitate innovation and growth. Bpifrance was formed from the merger of several entities in July 2013, including OSEO, CDC Entreprises, and FSI, to enhance its role in supporting the financing of the French economy.

Laurent Arthaud

Managing Director

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Cross-Functional Investments Venture Capital

Elyssa Maufras du Châtellier

Investment Director

Charlotte Corbaz

Deputy Director of the Large Venture Fund and Deputy Managing Director

Sofia Dahoune

Associate

Vanessa Giraud

Managing Director

Laurent Higueret

Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund

Hortense Jacon

Investment Associate

Veronique Jacq

Head of Digital Venture team

So-Yeon Koo

Senior Investment Manager

Eric Lefebvre

Director

Arnaud Legardeur

Investment Director

Serge Mesguich

Director

Louis Molis

Investment Director

Adrien Neel

Investment Director

Gilles Schang

Deputy Director

Tuan Tran

Investment Director / VC

Past deals in Dental

Dianosic

Seed Round in 2023
Dianosic SAS is a healthcare organization based in Strasbourg, France, founded in 2017. The company specializes in developing innovative medical devices for Ear, Nose, and Throat (ENT) conditions. Its flagship product, the CAVI-T, is an asymmetrical intranasal balloon designed to manage spontaneous or postoperative bleeding through low-pressure compression, tailored to the unique anatomy of the nasal cavity. This device also features an active balloon that minimizes biofilm formation, targets specific bacteria, and promotes healing. Additionally, Dianosic is developing an Active Resorbable Intranasal Scaffold device aimed at treating chronic sinusitis in patients who do not respond to conventional drug therapies. These advancements enable healthcare professionals to monitor patients remotely, enhancing post-operative care and overall treatment efficacy.

Doctolib

Series F in 2022
Doctolib is an online booking platform and management software provider based in Paris, France, that serves the healthcare sector across Europe. Established in 2013, the platform connects patients with healthcare practitioners, facilitating the scheduling of appointments with ease. With 25 million monthly visitors, it supports 65,000 health practitioners in over 1,300 facilities, offering a comprehensive service that enhances appointment management, reduces no-show rates, and attracts new patients. For patients, Doctolib provides a free service that allows them to find nearby doctors or dentists and book appointments 24/7 in just a few clicks. The platform aims to streamline access to healthcare services for both practitioners and patients, improving overall efficiency in the healthcare system.

Dianosic

Seed Round in 2020
Dianosic SAS is a healthcare organization based in Strasbourg, France, founded in 2017. The company specializes in developing innovative medical devices for Ear, Nose, and Throat (ENT) conditions. Its flagship product, the CAVI-T, is an asymmetrical intranasal balloon designed to manage spontaneous or postoperative bleeding through low-pressure compression, tailored to the unique anatomy of the nasal cavity. This device also features an active balloon that minimizes biofilm formation, targets specific bacteria, and promotes healing. Additionally, Dianosic is developing an Active Resorbable Intranasal Scaffold device aimed at treating chronic sinusitis in patients who do not respond to conventional drug therapies. These advancements enable healthcare professionals to monitor patients remotely, enhancing post-operative care and overall treatment efficacy.

Deeplink Medical

Venture Round in 2019
Deeplink-Medical is the answer to the real needs of the field apprehended by the founding medical team and the inadequacy of available telemedicine IT solutions. The design of innovative tools led by an experienced medical team, coupled with a framework of practices (support, training, medical protocol, activity monitoring) ensure the success of a telemedicine project and the optimization of the management patients.

Doctolib

Series E in 2019
Doctolib is an online booking platform and management software provider based in Paris, France, that serves the healthcare sector across Europe. Established in 2013, the platform connects patients with healthcare practitioners, facilitating the scheduling of appointments with ease. With 25 million monthly visitors, it supports 65,000 health practitioners in over 1,300 facilities, offering a comprehensive service that enhances appointment management, reduces no-show rates, and attracts new patients. For patients, Doctolib provides a free service that allows them to find nearby doctors or dentists and book appointments 24/7 in just a few clicks. The platform aims to streamline access to healthcare services for both practitioners and patients, improving overall efficiency in the healthcare system.

Doctolib

Series D in 2017
Doctolib is an online booking platform and management software provider based in Paris, France, that serves the healthcare sector across Europe. Established in 2013, the platform connects patients with healthcare practitioners, facilitating the scheduling of appointments with ease. With 25 million monthly visitors, it supports 65,000 health practitioners in over 1,300 facilities, offering a comprehensive service that enhances appointment management, reduces no-show rates, and attracts new patients. For patients, Doctolib provides a free service that allows them to find nearby doctors or dentists and book appointments 24/7 in just a few clicks. The platform aims to streamline access to healthcare services for both practitioners and patients, improving overall efficiency in the healthcare system.

Doctolib

Series C in 2017
Doctolib is an online booking platform and management software provider based in Paris, France, that serves the healthcare sector across Europe. Established in 2013, the platform connects patients with healthcare practitioners, facilitating the scheduling of appointments with ease. With 25 million monthly visitors, it supports 65,000 health practitioners in over 1,300 facilities, offering a comprehensive service that enhances appointment management, reduces no-show rates, and attracts new patients. For patients, Doctolib provides a free service that allows them to find nearby doctors or dentists and book appointments 24/7 in just a few clicks. The platform aims to streamline access to healthcare services for both practitioners and patients, improving overall efficiency in the healthcare system.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.